Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_assertion type Assertion NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_head.
- NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_assertion description "[However, the majority of breast cancer cell lines studied (11 of 12) expressed very low or undetectable levels of NPGPx irrespective of BRCA1 status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_provenance.
- NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_assertion evidence source_evidence_literature NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_provenance.
- NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_assertion SIO_000772 15294905 NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_provenance.
- NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_assertion wasDerivedFrom befree-2016 NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_provenance.
- NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_assertion wasGeneratedBy ECO_0000203 NP454731.RAiLdlt3AdMKwHZOYWDikx9pb6d63dRBO2aTRvqfUw3nw130_provenance.